FDA Approved: HALAVEN — Original Application (BSP Pharmaceuticals SpA)

View source ↗

Summary

FDA approved the original application for HALAVEN (eribulin mesylate) by BSP Pharmaceuticals SpA for metastatic breast cancer in patients who have previously re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Halaven (eribulin)

Snippet

ORIG AP for HALAVEN (ERIBULIN MESYLATE)